Literature DB >> 6561229

Quantitation of complement factor D in human serum by a solid-phase radioimmunoassay.

S R Barnum, M A Niemann, J F Kearney, J E Volanakis.   

Abstract

A sensitive solid-phase radioimmunoassay is described which quantitates human D to 1-2 ng/ml. The assay was used to measure the concentration of D in normal and acute-phase sera and sera from individuals with systemic lupus erythematosus. All 3 groups of sera had comparable levels of D with mean values of 1.8, 2.3 and 2.5 micrograms/ml, respectively. Also tested were sera decomplemented in vitro by activators of the classical and alternative pathways. The results indicated that D is not depleted by alternative or classical pathway activation. However, heat inactivation (56 degrees C, 30 min) of serum resulted in almost complete loss of antigenic D.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6561229     DOI: 10.1016/0022-1759(84)90470-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Inhibiting alternative pathway complement activation by targeting the factor D exosite.

Authors:  Kenneth J Katschke; Ping Wu; Rajkumar Ganesan; Robert F Kelley; Mary A Mathieu; Philip E Hass; Jeremy Murray; Daniel Kirchhofer; Christian Wiesmann; Menno van Lookeren Campagne
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

Review 2.  Complement factor D, a novel serine protease.

Authors:  J E Volanakis; S V Narayana
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

3.  Investigation of an albumin-enriched fraction of human serum and its albuminome.

Authors:  Rebekah L Gundry; Qin Fu; Christine A Jelinek; Jennifer E Van Eyk; Robert J Cotter
Journal:  Proteomics Clin Appl       Date:  2007-01-01       Impact factor: 3.494

4.  Complement factor D, albumin, and immunoglobulin G anti-band 3 protein antibodies mimic serum in promoting rosetting of malaria-infected red blood cells.

Authors:  Alexander Luginbühl; Milica Nikolic; Hans Peter Beck; Mats Wahlgren; Hans U Lutz
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

5.  Human complement protein D catabolism by the rat kidney.

Authors:  P W Sanders; J E Volanakis; S G Rostand; J H Galla
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

6.  Complete and partial deficiencies of complement factor D in a Dutch family.

Authors:  P S Hiemstra; E Langeler; B Compier; Y Keepers; P C Leijh; M T van den Barselaar; D Overbosch; M R Daha
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Production and interferon-gamma-mediated regulation of complement component C2 and factors B and D by the astroglioma cell line U105-MG.

Authors:  S R Barnum; Y Ishii; A Agrawal; J E Volanakis
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

8.  Complement factor D in age-related macular degeneration.

Authors:  Chloe M Stanton; John R W Yates; Anneke I den Hollander; Johanna M Seddon; Anand Swaroop; Dwight Stambolian; Sascha Fauser; Carel Hoyng; Yi Yu; Kanda Atsuhiro; Kari Branham; Mohammad Othman; Wei Chen; Elod Kortvely; Kevin Chalmers; Caroline Hayward; Anthony T Moore; Baljean Dhillon; Marius Ueffing; Alan F Wright
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-11       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.